Stay updated on Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.

Latest updates to the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; the content and function of the study page remain unchanged.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no clinical content or study details were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check47 days agoChange DetectedGlossary display was added to aid understanding of terms in the study record. The update history/footer were revised to show 'Last Update Submitted that Met QC Criteria', display 'No FEAR Act Data', and update the site revision to v3.4.0, replacing the previous labels.SummaryDifference0.2%

- Check61 days agoChange DetectedRevision: v3.3.4 was added to the page footer, replacing the previous v3.3.3. This is a minor update with no changes to study details or functionality.SummaryDifference0.1%

- Check83 days agoChange DetectedThe Locations section now includes recruitment sites in New Jersey and New York, with the locations updated accordingly. The HHS Vulnerability Disclosure footer link has been removed and previous location subsections were replaced in the new version.SummaryDifference0.3%

Stay in the know with updates to Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.